These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6208666)

  • 1. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
    Whitnack E; Dale JB; Beachey EH
    Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
    Sandin C; Carlsson F; Lindahl G
    Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular structure and immunochemistry of streptococcal M-protein].
    Ookuni H
    Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
    Johnsson E; Berggård K; Kotarsky H; Hellwage J; Zipfel PF; Sjöbring U; Lindahl G
    J Immunol; 1998 Nov; 161(9):4894-901. PubMed ID: 9794423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common protective antigens of group A streptococcal M proteins masked by fibrinogen.
    Whitnack E; Dale JB; Beachey EH
    J Exp Med; 1984 Apr; 159(4):1201-12. PubMed ID: 6368736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
    Jacks-Weis J; Kim Y; Cleary PP
    J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer.
    Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV
    Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M antigens of group A streptococci isolated by means of immunochromatography. Biochemical and serological properties.
    Kühnemund O; Havlicek J; Knöll H; Sjöquist J
    Immunobiology; 1981; 159(3):244-55. PubMed ID: 7021402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
    McArthur JD; Walker MJ
    Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
    Kaminskiĭ GD; Beliakov VD
    Vestn Akad Med Nauk SSSR; 1986; (7):10-7. PubMed ID: 2428180
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.
    Kawabata S; Kunitomo E; Terao Y; Nakagawa I; Kikuchi K; Totsuka K; Hamada S
    Infect Immun; 2001 Feb; 69(2):924-30. PubMed ID: 11159987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway.
    Carlsson F; Sandin C; Lindahl G
    Mol Microbiol; 2005 Apr; 56(1):28-39. PubMed ID: 15773976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopes of streptococcal M proteins shared with cardiac myosin.
    Dale JB; Beachey EH
    J Exp Med; 1985 Aug; 162(2):583-91. PubMed ID: 2410530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of group A type 1 streptococcal M protein with fibrinogen.
    Kühnemund O; Havlicek J; Knöll H; Sjöquist J; Köhler W
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):201-9. PubMed ID: 3898717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.